DIG
JAZZ icon

DeepCurrents Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

DeepCurrents Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-480
Closed -$7.47M – 236
2022
Q1 		$7.47M Buy
+480
New +$69.7K 0.23% 91

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

DeepCurrents Investment Group's JAZZ Position: Q2 2026 in Review

DeepCurrents Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q2 2026, buying an estimated $1.81M and bringing the position to 79,900 shares worth $19.3M. The position accounts for 0.58% of the portfolio, ranked #58.

DeepCurrents Investment Group first reported a position in JAZZ in Q4 2018 and has held it in 12 quarters since. The position peaked at $26.3M in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • DeepCurrents Investment Group held 79,900 shares of Jazz Pharmaceuticals worth $19.3M as of Q2 2026.
  • DeepCurrents Investment Group bought 8,264 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.81M.
  • Jazz Pharmaceuticals made up 0.58% of DeepCurrents Investment Group's portfolio in Q2 2026, its #58 holding.
  • DeepCurrents Investment Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 12 quarters since.
  • DeepCurrents Investment Group's Jazz Pharmaceuticals position peaked at $26.3M in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on DeepCurrents Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.